BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 8.72% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 8.04% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 6.98% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 6.36% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 5.64% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 5.45% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 4.99% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.69% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.21% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 4.11% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.28% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 3.26% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 3.07% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.03% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 2.56% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 2.42% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.40% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 2.20% |
| PACB | Pacific Biosciences of California | Healthcare | Medical Devices | 2.07% |
| BFLY | Butterfly Network Inc | Healthcare | Medical Devices | 2.03% |